Human Molecular Genetics Advance Access originally published online on January 3, 2008
Human Molecular Genetics 2008 17(7):1052-1060; doi:10.1093/hmg/ddm378
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ALOX5 variants associated with susceptibility to human pulmonary tuberculosis
1 Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany 2 Institute of Medical Biometry and Statistics, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany 3 National Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany 4 Department of Community Health, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana 5 Health Research Unit, Ghana Health Service, Accra, Ghana 6 Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana 7 Department of Pharmaceutical Analytics, Institute of Pharmacy, Eberhard Karls University, Tuebingen, Germany
* To whom correspondence should be addressed at: Bernhard Nocht Institute for Tropical Medicine, Bernhard Nocht Str. 74, 20359 Hamburg, Germany. Tel: +49 4042818501; Fax: +49 4042818512; Email: c.g.meyer{at}bni-hamburg.de
Received September 26, 2007; Revised November 29, 2007; Accepted December 21, 2007
The 5-lipoxygenase (ALOX5)-derived lipid mediators leukotrienes and lipoxins have regulatory functions in inflammation by modulating activities of immune cells and cytokine production. Recently, it was shown in ALOX5–/– mice that host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase (5-LO). ALOX5 polymorphisms were genotyped in 1916 sputum-positive patients with pulmonary tuberculosis (TB) from Ghana and in 2269 exposed, apparently healthy controls. Polymorphisms of a variable number of tandem repeats (VNTR) of the ALOX5 promoter and of the exonic non-synonymous variant g.760G>A were analysed by fragment length determination and fluorescence resonance energy transfer, respectively, and DNA sequencing. Mycobacterial lineages of >1400 isolates were differentiated biochemically and genetically. Carriers of one variant (n repeats 
5) and one wild-type VNTR allele (n = 5) or of the exonic allele g.760A had a higher risk of TB [Pcorrected = 0.026, odds ratio (OR) 1.19 (95% CI 1.04–1.37) and Pcorrected = 0.026, OR 1.21 (95% CI 1.04–1.41), respectively]. The association of the exonic variant was stronger in infections caused by the mycobacterial lineage M. africanum West-African 2 [Pcorrected = 0.024, OR 1.70; (95% CI 1.2–2.6)]. Determination of haplotypes revealed the strongest associaton with TB for the ‘non-5/760A’ haplotype compared with the ‘non-5/760G’ haplotype (P = 0.003, OR 1.50). Our observation of an association of ALOX5 variants with susceptibility to TB contributes evidence of the importance of 5-LO products to the regulation of immune responses to M. tuberculosis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. Radmark and B. Samuelsson 5-Lipoxygenase: mechanisms of regulation J. Lipid Res., April 1, 2009; 50(Supplement): S40 - S45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Thye, S. Nejentsev, C. D. Intemann, E. N. Browne, M. A. Chinbuah, J. Gyapong, I. Osei, E. Owusu-Dabo, L. R. Zeitels, F. Herb, et al. MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana, West Africa Hum. Mol. Genet., January 15, 2009; 18(2): 381 - 388. [Abstract] [Full Text] [PDF]
|
|